J D Horowitz
Overview
Explore the profile of J D Horowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
1606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hurst N, Nooney V, Raman B, Chirkov Y, De Caterina R, Horowitz J
Vascul Pharmacol
. 2013 Oct;
59(5-6):152-61.
PMID: 24140755
The clinical efficacy of the P2Y12 receptor antagonist clopidogrel as an agent to prevent thrombotic events predominantly reflects its anti-aggregatory effects. Stent thrombosis in particular is more likely to occur...
12.
Dautov R, Ngo D, Licari G, Liu S, Sverdlov A, RITCHIE R, et al.
Nitric Oxide
. 2013 Sep;
35:72-8.
PMID: 24012721
Impaired platelet responsiveness to nitric oxide (NO resistance) is a common characteristic of many cardiovascular disease states and represents an independent risk factor for cardiac events and mortality. NO resistance...
13.
Ngo D, Sverdlov A, Horowitz J
Pharmacol Ther
. 2012 Apr;
135(1):78-93.
PMID: 22516738
Aortic valve stenosis (AS) is the most common form of valvular heart disease in the Western world, affecting ~40% of the population over the age of 80; to date the...
14.
Sverdlov A, Ngo D, Horowitz J
J Intern Med
. 2012 Feb;
271(6):569-72.
PMID: 22324298
No abstract available.
15.
Rogers N, Stephenson M, Kitching A, Horowitz J, Coates P
Br J Pharmacol
. 2011 Jul;
166(1):194-209.
PMID: 21745189
Background And Purpose: Renal ischaemia-reperfusion (IR) injury is an inevitable consequence of renal transplantation, causing significant graft injury, increasing the risk of rejection and contributing to poor long-term graft outcome....
16.
Ngo D, Chan W, Rajendran S, Heresztyn T, Amarasekera A, Sverdlov A, et al.
Nitric Oxide
. 2011 Jul;
25(3):326-30.
PMID: 21741493
Background: Polycystic ovary syndrome (PCOS) is associated with incremental risk of atherosclerosis and possibly of cardiovascular events. Insulin resistance (IR) occurs frequently in PCOS subjects, which might be one of...
17.
Sverdlov A, Ngo D, Nightingale A, Rajendran S, Mishra K, Heresztyn T, et al.
Nitric Oxide
. 2011 May;
25(1):41-6.
PMID: 21550414
Background: Nitric oxide (NO) is a modulator of left ventricular hypertrophy (LVH) and myocardial relaxation. The impact of NO availability on development of LVH has never been demonstrated in humans....
18.
Willoughby S, Chirkova L, Horowitz J, Chirkov Y
Platelets
. 2010 Nov;
7(5-6):329-33.
PMID: 21043669
We tested the hypothesis that utilisation of multiple agonists in physiological concentrations is more appropriate for platelet aggregation in vitro than a single agonist in high concentration. Utilising impedance aggregometry...
19.
Sorich M, Vitry A, Ward M, Horowitz J, McKinnon R
J Thromb Haemost
. 2010 May;
8(8):1678-84.
PMID: 20492467
Background: Prasugrel is a newly marketed antiplatelet drug with improved cardiac outcomes as compared with clopidogrel for acute coronary syndromes involving percutaneous coronary intervention (PCI). Analysis of a subset of...
20.
Mishra K, Sage P, Philpott A, Zeitz C, Horowitz J
Intern Med J
. 2006 Jun;
36(7):458-61.
PMID: 16780454
The need for on-site cardiac surgery has been a component of guidelines for the practice of elective and emergency percutaneous coronary intervention (PCI). However, proportions of cases requiring emergency coronary...